| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Sage Therapeutics, Inc. | Director | Common Stock | 3,000 | $4,080 | $1.36 | 09 Aug 2023 | Direct |
| Sage Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 12,500 | 10 Jun 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| SAGE | Sage Therapeutics, Inc. | 10 Jun 2024 | 1 | $0 | 4 | Director | 11 Jun 2024, 16:57 |
| SAGE | Sage Therapeutics, Inc. | 09 Aug 2023 | 1 | +$37,279 | 4 | Director | 11 Aug 2023, 08:51 |
| SAGE | Sage Therapeutics, Inc. | 15 Jun 2023 | 1 | $0 | 4 | Director | 16 Jun 2023, 16:06 |
| SAGE | Sage Therapeutics, Inc. | 09 May 2023 | 1 | +$50,500 | 4 | Director | 11 May 2023, 08:58 |
| SAGE | Sage Therapeutics, Inc. | 16 Jun 2022 | 1 | $0 | 4 | Director | 17 Jun 2022, 16:35 |
| SAGE | Sage Therapeutics, Inc. | 04 Jan 2022 | 1 | $0 | 4 | Director | 05 Jan 2022, 15:08 |
| SAGE | Sage Therapeutics, Inc. | 10 Jun 2021 | 1 | $0 | 4 | Director | 11 Jun 2021, 16:09 |